drugset / Trial / NCT01327027
Vasopressin Effects on Human Social Communication
Phase 1
Completed
225 enrolled
Bowdoin College
MaineHealth · collabNational Institute of Mental Health (NIMH) · collab
RandomizedCrossoverDouble-blindBasic science
Summary
This research is being done because we wish to understand how a chemical produced in the brain, vasopressin, effects emotional social communication processes. Understanding how this system works in normal individuals may help us understand why some people, particularly those with autism and/or antisocial personality disorder, have dysfunctional social interactions. This study will test the effects of 3 doses of arginine vasopressin, delivered intranasally, on physiological and behavioral responses to the faces of same- and other-sex individuals in healthy men and women.
Timeline
- Start
- 2011-09
- Primary completion
- 2015-12
- Completion
- 2017-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vasopressin | Peptide | 20 iu | Intranasal |
| Subject | Vasopressin | Peptide | 40 iu | Intranasal |
Indications
No indication recorded.